Nyxoah introduces neurostimulator device for sleep apnoea in England
Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first…
Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first…
Beyond Air has gained CE mark approval for its LungFit PH system, permitting the marketing of the device within the…
Plus Therapeutics subsidiary CNSide Diagnostics has reported data from the multi-centre FORESEE trial, which highlights the CNSide cerebrospinal fluid (CSF)…
Sheba Medical Center's innovation arm, Accelerate, Redesign, and Collaborate (ARC), has partnered with Roche to advance the diagnosis and treatment…
Medical technology company SoundHealth has launched SONUCheck, a vocal analysis feature in the SONU app that uses AI to measure…
Researchers at the Mayo Clinic in the US have developed a new testing strategy aimed at improving mesothelioma cancer deoxyribonucleic…
PrognomiQ has closed its Series D financing round, securing $34m, for advancing the development of an early lung cancer detection…
Baxter International has launched its next-generation airway clearance system, The Vest advanced pulmonary experience (APX) system, aimed at supporting therapy…
Roche has introduced the cobas Respiratory flex test, a new diagnostic that utilises the company's temperature-activated generation of signal (TAGS)…
Huxley Medical has received the US Food and Drug Administration (FDA) 510(k) clearance for its SANSA sleep apnoea diagnostic patch.…